Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 14/20 | 0.56 |
| ▸ | CA1 | P00915 | 13/20 | 0.52 |
| ▸ | MMP1 | P03956 | 4/20 | 0.52 |
| ▸ | MMP2 | P08253 | 4/20 | 0.52 |
| ▸ | MMP9 | P14780 | 4/20 | 0.52 |
| ▸ | MMP8 | P22894 | 4/20 | 0.52 |
| ▸ | MMP13 | P45452 | 4/20 | 0.52 |
| ▸ | F2 | P00734 | 4/20 | 0.46 |
| ▸ | PRSS1 | P07477 | 4/20 | 0.46 |
| ▸ | PRSS2 | P07478 | 4/20 | 0.46 |
| ▸ | PRSS3 | P35030 | 4/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL585308 | 1.00 | CA2 (0.56) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL584864 | 1.00 | CA2 (0.56) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL584177 | 1.00 | CA2 (0.56) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL585171 | 1.00 | CA2 (0.56) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL3838335 | 1.00 | CA2 (0.56) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL7660482 | 1.00 | CA2 (0.56) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL73684 | 0.97 | CA2 (0.52) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL6898759 | 0.94 | CA2 (0.50) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL13684270 | 0.91 | CA2 (0.43) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL11788241 | 0.91 | CA2 (0.43) | CA2CA1MMP1MMP2MMP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1014 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4196846-B1 | ELECTROCHROMIC BI-LAYERED DEVICES FOR DYNAMIC LIGHT THROUGHPUT CONTROL AND A PROCESS FOR THE PREPARATION THEREOF | COUNCIL SCIENT IND RES (IN) | 2026-03-04 | — | — | EP | claimed |
| US-20260008706-A1 | Utilization of Micro Hydroflocs for the Effective and Complete Removal of Long and Short Chain PFAS Molecules from Contaminated Water | StreamGo Water USA LLC (US) | 2026-01-08 | — | — | US | claimed |
| US-20250316473-A1 | METHOD OF DEPOSITING THIN LAYER | KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2025-10-09 | — | — | US | claimed |
| EP-4628454-A1 | REMOVAL OF DIOXANE AND OTHER RECALCITRANT CONTAMINANTS FROM WATER USING NANOBUBBLES IN ADVANCED OXIDATION PROCESSES | StreamGo Water USA LLC (US) | 2025-10-08 | — | — | EP | claimed |
| US-20250304478-A1 | Removal of Dioxane and other Contaminants from Water using Oxygen Nanobubbles in Advanced Oxidation Processes | StreamGo Water USA LLC (US) | 2025-10-02 | — | — | US | claimed |
| CN-120138977-A | Organosilicon wetting agent for fabrics and preparation method thereof | 上海氟聚化学产品股份有限公司 | 2025-06-13 | — | — | CN | claimed |
| CN-119685802-B | Initiating molecular layer deposition method and regioselective deposition regulation and control method | 浙江大学 | 2025-05-30 | — | — | CN | claimed |
| CN-117984635-B | Antibacterial composite non-woven fabric | 广州三立无纺布有限公司 | 2025-05-09 | — | — | CN | claimed |
| CN-119931443-A | High-weather-resistance solvent-free coating and preparation method thereof | 苏州博纳化学科技有限公司 | 2025-05-06 | — | — | CN | claimed |
| US-12290835-B2 | Methods for stabilization of self-assembled monolayers (SAMs) using sequentially pulsed initiated chemical vapor deposition (spiCVD) | TOKYO ELECTRON LIMITED (JP) | 2025-05-06 | — | — | US | claimed |
| EP-0735992-B1 | METHOD OF CONVERTING HYDROXYL GROUPS INTO CORRESPONDING FLUORO COMPOUNDS | BAYER AG (DE) | 2001-01-03 | — | — | EP | claimed |
| WO-2000031003-A1 | PROCESS FOR CONVERTING AN ALCOHOL TO THE CORRESPONDING FLUORIDE | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2000-06-02 | — | — | WO | claimed |
| EP-0861224-A1 | PROCESS FOR PREPARING FLUOROCARBOXYLIC ACID HALIDES | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1998-09-02 | — | — | EP | claimed |
| US-5760255-A | Process for the conversion of hydroxyl groups into the corresponding fluorine compounds | BAYER AG (DE) | 1998-06-02 | — | — | US | claimed |
| EP-0582192-B1 | Bipolar flow cell and process for electrochemical fluorination | MINNESOTA MINING & MFG (US) | 1997-08-27 | — | — | EP | claimed |
| WO-1997019046-A1 | PROCESS FOR PREPARING FLUOROCARBOXYLIC ACID HALIDES | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1997-05-29 | — | — | WO | claimed |
| US-5616794-A | Process for preparing fluorocarboxylic acid halides | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1997-04-01 | — | — | US | claimed |
| US-5364507-A | Process for the production of perfluoroalkylsulphonyl fluorides and electrodes for performance of the process | BAYER AG (DE) | 1994-11-15 | — | — | US | claimed |
| US-5322597-A | Bipolar flow cell and process for electrochemical fluorination | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1994-06-21 | — | — | US | claimed |
| EP-0582192-A1 | Bipolar flow cell and process for electrochemical fluorination | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1994-02-09 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260008706-A1 | Utilization of Micro Hydroflocs for the Effective and Complete Removal of Long and Short Chain PFAS Molecules from Contaminated Water | PFAS, FGB, F8 | CA2 1892/4885CA1 2357/4885MMP1 3481/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.